Bank of New York Mellon’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

Bank of New York Mellon’s Portfolio ALXA Stock Details ALXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-35,767	Closed	-$17K	–	4382
2016 Q1	$17K	Buy	35,767 +1,745	+5%	+$763	﹤0.01%	4177
2015 Q4	$24K	Sell	34,022 -589	-2%	-$607	﹤0.01%	4264
2015 Q3	$43K	Buy	34,611 +589	+2%	+$688	﹤0.01%	4260
2015 Q2	$37K	Buy	34,022 +410	+1%	+$615	﹤0.01%	4189
2015 Q1	$69K	Buy	33,612 +167	+0.5%	+$343	﹤0.01%	4113
2014 Q4	$50K	Hold	33,445	–	–	﹤0.01%	4147
2014 Q3	$78K	Hold	33,445	–	–	﹤0.01%	4106
2014 Q2	$153K	Buy	33,445 +26	+0.1%	+$112	﹤0.01%	3904
2014 Q1	$148K	Buy	33,419 +6,402	+24%	+$32.8K	﹤0.01%	3914
2013 Q4	$128K	Hold	27,017	–	–	﹤0.01%	3970
2013 Q3	$138K	Hold	27,017	–	–	﹤0.01%	3887
2013 Q2	$117K	Buy	+27,017	New	+$122K	﹤0.01%	3899

Bank of New York Mellon's ALXA Position: Q2 2016 in Review

Bank of New York Mellon sold out of Alexza Pharmaceuticals Inc (ALXA) in Q2 2016, closing a stake of 35,767 shares — an estimated $17K sold.

Bank of New York Mellon first reported a position in ALXA in Q2 2013 and held it in 12 quarters. The position peaked at $153K in Q2 2014. 0 funds tracked by Wall St. Rank hold ALXA as of Q2 2016.

Bank of New York Mellon reported no remaining Alexza Pharmaceuticals Inc position as of Q2 2016 after selling out during the quarter.
Bank of New York Mellon sold 35,767 Alexza Pharmaceuticals Inc shares in Q2 2016, an estimated $17K.
Bank of New York Mellon first reported a position in Alexza Pharmaceuticals Inc in Q2 2013 and held it in 12 quarters.
Bank of New York Mellon's Alexza Pharmaceuticals Inc position peaked at $153K in Q2 2014.
0 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q2 2016.

Based on Bank of New York Mellon's 13F filing for Q2 2016, filed 1 Aug 2016.